期刊文献+

天麻钩藤饮加减治疗肝阳上亢型高血压病临床分析 被引量:19

Clinical Analysis of Gastrodia and Uncaria Decoction Treatment of Liver Yang Type of Hypertension
下载PDF
导出
摘要 目的:观察天麻钩藤饮对肝阳上亢型高血压病患者的疗效及其生活质量的影响。方法:选择肝阳上亢型高血压病人172例,随机分为治疗组86例和对照组86例,治疗组采天麻钩藤饮加减治疗,对照组采用洛汀新治疗,两组均治疗4周,分别对两组的血压和生活质量进行测评。结果:治疗后,两组血压均明显下降,两组间比较差异无统计学意义(P>0.05),而治疗组生活质量评分明显较对照组高(P<0.001)。结论:天麻钩藤饮对肝阳上亢型高血压病患者不但具有良好的降压效果,还能够明显提高高血压患者的生活质量。 Objective:To observe the Gastrodia and Uncaria Decoction on liver yang hypertensive patients the efficacy and quality of life impact. Methods:172 cases of liver yang hypertensive patients,86 cases were randomly divided into treatment group and control group 86 cases,the treatment group to adopt Gastrodia and Uncaria decoction treatment,control group Lotensin treatment,both groups were treated 4 weeks,respectively,the two groups of blood pressure and quality of life for evaluation. Results:After treatment,both groups were significantly decreased blood pressure between the two groups no statistically significant difference (P0.05),while the treatment group,the quality of life score was significantly higher than the control group (P0.001).Conclusion:Gastrodia and Uncaria Decoction on liver yang hypertensive patients with blood pressure lowering effect is not only good,but also can significantly improve the quality of life in patients with hypertension.
出处 《辽宁中医药大学学报》 CAS 2010年第2期154-155,共2页 Journal of Liaoning University of Traditional Chinese Medicine
关键词 天麻钩藤饮 高血压病 临床分析 gastrodia and uncaria decoction essential hypertension clinical analysis
  • 相关文献

参考文献5

二级参考文献7

  • 1于普林 杨超元 何慧德.老年人生活质量调查内容及评价标准建议(草案)[J].中华老年医学杂志,1996,15(5):320-320. 被引量:78
  • 26,International Resource Center for Health Care Assesment.How to score the MOS 36-itemshort-item health survey(SF-36).Boston:The Health Institute,1992:197~216 被引量:1
  • 37,StreinerDL,NormanGR.Healthmeasurementscales:apracticalguidetotheirdevelopmentanduse.Oxford:OxfordUniversityPress,1989:39-52 (2000-04-07收稿2000-07-27修回) 被引量:1
  • 41,Bulpitt CJ,Flether AE.Quality oflife evaluation of antihypertensive drugs.Pharmacoeconomics,1992,1(2):95 被引量:1
  • 52,Kong BW,Bean JA,Stephens D.Assessment of the vital signs quality of life.Questionnairein three studies on hypertension.J Hum Hypertens,1995,9(3):255 被引量:1
  • 63,Bulpitt CJ,Flether AE.The measurement of quality of life in hypertensive patients:apractical approach.Br J Clin Pharmac,1990,30(4):353 被引量:1
  • 74,Ware JE,Sherboune CD.The MOS 36-item short-form health survey (SF-36):1.Conceptualframework and item selection.Medical Care,1992,30(5):473. 被引量:1

共引文献450

同被引文献150

引证文献19

二级引证文献171

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部